(Q39413387)

English

Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models

scientific article published on 11 January 2012

Statements

Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models (English)
Joseph M Gozgit
Matthew J Wong
Lauren Moran
Scott Wardwell
Qurish K Mohemmad
Narayana I Narasimhan
William C Shakespeare
Frank Wang
Tim Clackson
Victor M Rivera
11 January 2012
690-699

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit